Current financial headlines
Sharemaestro Newsreel
Financial news from across the world, newest first. Choose a country or market group, open the source, or continue into the company data.
- Showing
- 37–72
- Headlines
- 212
- Sources here
- 16
- Companies here
- 15
Current section
Canada Drug Manufacturers - Specialty & Generic news
Chronological news
Earlier headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Cipher Pharmaceuticals Reports Second Quarter 2026 Results
(All figures are presented in U.S. Dollars) Epuris® sales were $4.1 million during the quarter, a year-over-year increase of 14% compared to Q2 2025 and a sequential increase of 4% over Q1 2026 Letter of Intent executed with the pan-Canadian Pharmaceutical Alliance, securing expanded …
CPH
main company
Sharemaestro market context
Trend signal active
52 weeks +23.4%
DRI Healthcare Trust 2026 Q2 - Results - Earnings Call Presentation (TSX:DHT.UN:CA) 2026-08-11
Key Points Interested in DRI Healthcare Trust? Here are five stocks we like better. DRI Healthcare Trust reported record Q2 results: Total income rose 13% year over year to $50.1 million, cash receipts increased 16% to $46.5 million, and adjusted EBITDA climbed 40% to …
DHT-UN
main company
Sharemaestro market context
Trend signal active
52 weeks +27.2% · Next-week setup positive 55.8%
Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making?
Canopy Growth (NASDAQ: CGC) has spent the better part of the past five years destroying shareholder value. The stock is down more than 99% from its all-time high. The company has burned through billions of dollars, diluted shareholders repeatedly, exited non-core businesses, and cycled …
WEED
main company
Sharemaestro market context
Price below Trend Line
52 weeks -23.9% · Next-week setup negative 38.0%
DRI Healthcare Trust Q2 Earnings Call Highlights
Key Points Interested in DRI Healthcare Trust? Here are five stocks we like better. DRI Healthcare Trust reported record Q2 results: Total income rose 13% year over year to $50.1 million, cash receipts increased 16% to $46.5 million, and adjusted EBITDA climbed 40% to …
DHT-UN
main company
Sharemaestro market context
Trend signal active
52 weeks +27.2% · Next-week setup positive 55.8%
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Canopy Growth Posted 13% Revenue Growth as Losses Narrowed Sharply in Q1 FY2027 Aurora Cannabis Narrowed Q1 Loss as International Medical Cannabis Growth Gained Ground Cronos Group Reported Record Q2 Revenue as Profitability and EBITDA Surged Key Takeaways; Psychedelic Sector …
Sharemaestro market context Price below Trend Line 52 weeks -40.7%Aurora Cannabis Inc. 2027 Q1 - Results - Earnings Call Presentation (TSX:ACB:CA) 2026-08-08
Image source: The Motley Fool. DATE Wednesday, Aug. 5, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Executive Chairman and Chief Executive Officer - Miguel Martin Chief Financial Officer - Simona King Director of Strategic Finance and Investor Relations - Kevin Niland Full Conference Call …
ACB
main company
Sharemaestro market context
Price below Trend Line
52 weeks -40.7%
Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests – Quarterly Update Report
Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: International medical cannabis revenue increased 17% to C$43.3 million in 1Q FY27, reinforcing …
Sharemaestro market context Price below Trend Line 52 weeks -40.7%Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think
Key Points The United States is slowly moving toward the legalization of marijuana. The next big step is the rescheduling of the drug at the federal level, which won't make it legal, just less illegal. Canopy Growth's business won't be dramatically impacted either way.10 …
WEED
main company
Sharemaestro market context
Price below Trend Line
52 weeks -23.9% · Next-week setup negative 38.0%